Live Breaking News & Updates on Biomarkers

Stay informed with the latest breaking news from Biomarkers on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Biomarkers and stay connected to the pulse of your community

Garje Elucidates Biomarker-Driven Approaches Generating Excitement in Metastatic Prostate Cancer

Rohan Garje, MD, highlights advances made in precision medicine approaches for the management of metastatic prostate cancer.

Florida , United-states , Miami , Rohan-garje , Baptist-health-miami-cancer-institute , Baptist-health , Miami-cancer-institute , Baptist-healths-miami-cancer-institute , Metastatic-prostate-cancer , Precision-medicine , Biomarkers

Neurotech for Dementia Screening in Outpatient Clinical Markets

Diagnosis of Alzheimer's and related dementias is broken. As blood tests emerge, what is the role of digital screening tools and neurotechnologies in clinical practice?

United-states , Americans , Bill-gates , Rebecca-edelmayer , Howard-fillit , Public-health , Alzheimer-association , National-plan , Society-of-actuaries , Alzheimer-drug-discovery-foundation , Jp-morgan , Related-dementias-neurology-desert-index

Peripartum cardiomyopathy is associated with placental senescence

Scientists at Massachusetts General Hospital have linked the risk of heart failure during pregnancy and senescence proteins produced by placental aging, which could clarify how peripartum cardiomyopathy (PPCM) is triggered and opens the door to the development of cardiac function therapies in late pregnancy.

Massachusetts , United-states , Massachusetts-general-hospital , Bioworld-science , Senescence , Placenta , Peripartum-cardiomyopathy , Preeclampsia , Heart-failure , Cardiovascular , Biomarkers

How to harness biomarkers for rapid drug development

Expert perspectives on the role of biomarkers in drug development and personalized medicine

Biomarkers , Rug-development , Rug-discovery , Mmunoassays , Asld , Ash , Lzheimer-s , Ersonalized-medicine ,

Post-Thyroidectomy Management: Thyroid Hormone Replacement and TSH Suppression

The panel discusses the importance of thyroid hormone replacement and TSH suppression, highlighting the role of endocrinologists in managing the risk of cardiovascular disease. Dr. Brose also addresses the potential long-term risks associated with radioactive iodine treatment in the post-surgery setting, including cytopenia, salivary gland issues, and excessive tearing of the eyes.

Optimizing-therapy , Thyroidectomy-management , Thyroid-hormone-replacement , Tsh-suppression , Cardiovascular-disease , Biomarkers , Lesion , Ct-scan- ,

5 Startup Opportunities In Genomics

In this article we delve into five particularly promising areas within genomics where startups able to innovate are quite literally likely to change the world.

Consumer-genetic , Genomics , Startups , Genetics , Biomarkers , Synthetic-biology , Nutrigenomics ,

Leveraging Immunotherapy in GI Malignancies: Is Multicancer Early Detection Becoming a Reality?

In this episode of OncChats: Leveraging Immunotherapy in GI Malignancies, experts discuss the potential for early detection multiomic assays and the work that still needs to be done to encourage their widespread use.

Arizona , United-states , Phoenix , Toufic-kachaamy , Madappa-kundranda , Sunil-sharma , Banner-md-anderson-cancer-center , University-of-massachusetts-amherst , Cancer-center , Immunotherapy , Gastrointestinal-cancer , Multicancer-early-detection

Alamar Biosciences scoops up $128M for proteomics platform

Alamar Biosciences Inc.’s substantially oversubscribed series C pushed the company’s total funds raised to $250 million. The company closed the first $100 million on Feb. 26 and expects to close an additional $28 million within 30 days. The target for the series C was $100 million. The funds will be used to drive market adoption of its Argo HT system and nucleic acid linked immune-sandwich assay sequencing (NULISAseq) inflammation panel 250 for deep profiling of immune response.

Alamar-biosciences-inc , Alamar-biosciences , Bioworld-medtech , Alamar-biosciences-inc- , Argo-ht , Nulisa , Nulisaseq-250 , Biomarkers , Series-c , Us- , Diagnostics

Dr Punekar on the Importance of Complete Biomarker Testing in Lung Cancer

Salman R. Punekar, MD, discusses the importance of complete biomarker testing and the landscape of biomarkers in lung cancer.

Salmanr-punekar , Langone-perlmutter-cancer-center , Grossman-school-of-medicine , Perlmutter-cancer-center , Onclive-tv , Non-small-cell-lung-cancer , Nsclc , Biomarkers ,

Future Landscape of Chronic GVHD

Drs Yi-Bin Chen, Corey Cutler, Hannah Choe, and Mitchell Horwitz share their predictions for the next 3 to 5 years in chronic GVHD management. The panel anticipates advancements in earlier treatment, potential elimination of frontline corticosteroids, and a shift towards preventive strategies and personalized medicine.

Massachusetts , United-states , Dana-farber-cancer-institute , Corey-cutler , Hannah-choe , Bin-chen , Mitchell-horwitz , Marrow-transplant-program-at-duke-university , Ohio-state-university , Cell-therapy-program-at-massachusetts , Professor-of-medicine-at-harvard-medical-school , Cell-therapy-program